People: Pfizer Inc (PFE.N)
Dr. Mikael Dolsten, M.D., Ph.D., is the President - Worldwide Research and Development of the Company. He has been President of Worldwide Research and Development from December 2010 until December 2018. Senior Vice President; President of Worldwide Research and Development from May 2010 until December 2010. Senior Vice President; President of Pfizer BioTherapeutics Research & Development Group from October 2009 until May 2010. He was Senior Vice President of Wyeth and President, Wyeth Research from June 2008 until October 2009. He was a Private Equity Partner at Orbimed Advisors, LLC from January 2008 until June 2008. Director of Karyopharm Therapeutics Inc. Chairman of the Translational Advisory Board of Apple Tree Partners from 2016 to 2017.
|Total Annual Compensation, USD||2,632,250|
|Restricted Stock Award, USD||2,013,090|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||2,424,860|
|Fiscal Year Total, USD||7,070,200|